MENLO PARK, Calif.--(BUSINESS WIRE)--Montreux Equity Partners, L.L.C. (“Montreux” or “MEP”), today announced the close of Montreux Equity Partners IV, L.P. (“MEP IV”), a $250 million venture capital fund focused on therapeutic-oriented life sciences companies. With strong support from existing investors and new institutional investors, MEP IV exceeded its $200 million target and closed at its hard cap of investor commitments.
